ARTICLE | Company News

Gilead, Fair Pricing Coalition sales and marketing update

September 21, 2015 7:00 AM UTC

The coalition’s petition asks for comparable pricing between Gilead’s new TAF treatments and regimens containing Viread tenofovir disoproxil fumarate, a nucleotide analog prodrug reverse transcriptase inhibitor. Gilead’s new formulations may have a lower risk of bone and kidney toxicity than the older treatment. ...